(Q38278954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

review article

1 reference

title

Neuroinflammation as a possible link between cannabinoids and addiction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Livia C M Rodrigues

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Pedro H Gobira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Antonio Carlos de Oliveira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Renan Pelição

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Fabricio A Moreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Alline Cristina Campos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

1 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Acta Neuropsychiatrica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

334-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455257%20AND%20SRC:MED&resulttype=core&format=json

Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Hematological, immunological and neurochemical effects of chronic amphetamine treatment in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Stress-induced suppression of the immune system after withdrawal from chronic cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Neurochemical basis of interleukin 2-modified discrimination behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Regulation of the human serotonin transporter by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

CB1 receptor antagonists for the treatment of nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Mechanism-based medication development for the treatment of nicotine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Addiction and pain: cannabinoid and opioid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Behavioural assessment of drug reinforcement and addictive features in rodents: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB1 receptors control conditioned drug seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The role of CB1 receptors in psychostimulant addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The role of endocannabinoid transmission in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid system involvement in brain reward processes related to drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

'Macrophage' cannabinoid receptor goes up in smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Getting to the core of addiction: Hooking CB2 receptor into drug abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Anti-inflammatory properties of CB1-receptor antagonist involves beta2 adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

CB2: a cannabinoid receptor with an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Excitotoxicity in glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Involvement of the endocannabinoid system in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabinoid transmission and reward-related events

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

An endocannabinoid hypothesis of drug reward and drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The endocannabinoid system and its therapeutic exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

A historical overview of chemical research on cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Therapeutic perspectives of inhibitors of endocannabinoid degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Opposite effects of anandamide and N-arachidonoyl dopamine in the regulation of prostaglandin E and 8-iso-PGF formation in primary glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The cannabinoid system and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Marijuana's interaction with brain reward systems: update 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Effect of ethanol on inflammatory responses. Implications for pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Cannabis: discrimination of "internal bliss"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Serum cytokine concentrations in alcohol-dependent individuals without liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

The unfolding web of innate immune dysregulation in alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Current status of co-occurring mood and substance use disorders: a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Suppression of natural killer cell activity by ethanol consumption and food restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Disordered sleep, nocturnal cytokines, and immunity in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Effects of Δ9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Peroxisome proliferator-activated receptors: "key" regulators of neuroinflammation after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Minocycline reduces ethanol drinking

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Marijuana, immunity and infection

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Cannabis and the brain

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Cannabis, the mind and society: the hash realities

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Focal epithelial hyperplasia: Heck disease

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Major depression and immunity in alcohol-dependent persons

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Microglia and drug-induced plasticity in reward-related neuronal circuits

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2014.24

7 January 2021